Renal and Glucose-Lowering Effects of Empagliflozin and Dapagliflozin in Different Chronic Kidney Disease Stages

Renal and Glucose-Lowering Effects of Empagliflozin and Dapagliflozin in Different Chronic Kidney Disease Stages

Objective: The objective of this study was to investigate the effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on renal function in different stages of chronic kidney disease (CKD).Design and Methods: We conducted a retrospective cohort study using longitudinal claims data from May 2016–...

Full description

Bibliographic Details
Main Authors: Yi-Hsuan Lin, Yu-Yao Huang, Sheng-Hwu Hsieh, Jui-Hung Sun, Szu-Tah Chen, Chia-Hung Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Endocrinology
Subjects:
sodium–glucose cotransporter 2 inhibitors
renal function
acute kidney injury
Chang Gung Research Database
glucose control
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2019.00820/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2019.00820/full

Similar Items